Mettler-toledo International, Inc. · NYSE:MTD
Mettler-toledo International — JP Morgan Healthcare Conference 2024
25 slides from Mettler-toledo International's conference presentation, Jan 10, 2024
Slide 1: JP Morgan Healthcare Conference
January 10, 2024 JP Morgan Healthcare Conference Patrick Kaltenbach, CEO
Slide 2: Safe Harbor Statement
Safe Harbor Statement 2 Statements in this presentation which are not historical facts constitute “forward looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown
Slide 3: Long Term Track Record of Performance
Long Term Track Record of Performance 3 Growing Sales (1) Expanding Operating Margins (1) in mUSD 3,800 31% LC CAGR: 6% 28% 3,200 25% 22% 2,600 19% 2,000 16% 12 13 14 15 16 17 18 19 20 21 22 12 13 14 15 16 17 18 19 20 21 22 Strong EPS Growth (1) Excellent Shareholder Returns 800 $35.00 700 CAGR: 15%
Slide 4: Laboratory: Innovative Analysis for R&D Labs
Laboratory: Innovative Analysis for R&D Labs 4 Highest precision and flexibility in analysis and measurement to accelerate our customers R&D High-end Pipettes Analytical AutoChem LabX Software Automation Instruments Solutions Balance
Slide 5: Laboratory: Support for Effective Quality Control
Laboratory: Support for Effective Quality Control 5 Efficient processes in sample analysis and full support of customers regulatory and documentation requirements Balances Analytical Instruments LabX Software
Slide 6: Laboratory: Continuous Monitoring in Process Control
Laboratory: Continuous Monitoring in Process Control 6 Intelligent Sensor Management increases reliability of measurement results, eliminates waste and reduces downtime On-line TOC and pH, Conductivity, and Oxygen, CO2, and Transmitters Conductivity Analyzer Turbidity Sensors Pressure Sensors
Slide 7: Industrial: Comprehensive Solutions for Production
Industrial: Comprehensive Solutions for Production 7 Tailored weighing solutions for production and logistics, from formulation to data management Weighing Bench and Floor Software Load Cell and Logistics Terminals Scales Weigh Modules Solutions
Slide 8: Industrial: Product Inspection for Quality
Industrial: Product Inspection for Quality 8 Detection of physical contaminants and non-conformances in food Check Weighing Metal Detection X-ray Inspection Vision Inspection ProdX Software
Slide 9: Service Solutions Across the Entire Lifecycle
Service Solutions Across the Entire Lifecycle 9 Comprehensive service solutions to maintain quality, ensure compliance, and optimize performance Maximize Uptime Optimize Performance Ensure Compliance Enhance Expertise
Slide 10: Competitive Advantages
Competitive Advantages 10 Excellent brand, comprehensive Long history of innovation and Leader in fragmented markets product offering, installed base strong product portfolio Unique sophisticated sales and Direct sales network with excellent Superior and extensive global marketing programs applicati
Slide 11: Diversified Market Segments and Geographies
Diversified Market Segments and Geographies 11 Balanced sales mix across attractive market segments Life Sciences, Food Manufacturing, and Chemical markets represent over Other Life 70% of sales and benefit from favorable long-term structural growth drivers ~28% Sciences ~40% Attractive end mark
Slide 12: Spinnaker – Next Wave of Initiatives for Sales Excellence
Spinnaker 6 – Next Wave of Initiatives for Sales Excellence 12 Spinnaker focuses on Sales, Marketing, and Service, comprised of initiatives and processes to accelerate sales growth and improve profitability - Increase demand for our products, solutions and services via Leads Generation and Sales F
Slide 13: Service Growth Drivers
Service Growth Drivers 13 Service represents >20% of sales and a significant growth opportunity iBase Penetration Selling Service at POS Service Excellence Leveraging Big Data Analytics Ensure Uptime and Satisfaction Maximize Productivity Advanced iBase analysis Value-Selling Service content for
Slide 14: Recent Laboratory Product Innovation
Recent Laboratory Product Innovation 14 ISM 2.0 Process Analytics digital sensors DSC 5+ Thermal Analysis
Slide 15: Recent Industrial Product Innovation
Recent Industrial Product Innovation 15 PHD smart ultra-low profile hygienic floor scale X2 series X-ray inspection
Slide 16: Margin Enhancement
Margin Enhancement 16 Strong track record of continuous margin improvement Gross Margin Operating Margin (1) 60% 32% 59% 30% 28% Key Drivers: 58% 26% Organic sales growth 57% 24% Pricing program 56% 22% SternDrive initiatives 55% 20% Business mix 54% 18% 53% 16% 52% 14% 2011 2012 2013 2014 2
Slide 17: SternDrive
SternDrive 17 Global program for operational excellence and continuous improvement SternDrive PO Productivity and Supply Chain Efficiency Material Cost Reduction Shop-Floor Productivity Back-Office Productivity Focus on material cost reductions, manufacturing productivity and back-office productiv
Slide 18: Acquisition Strategy
Acquisition Strategy 18 Select acquisitions to enhance leadership or expand offering, primarily focused on Life Sciences/ Biopharma tools & software bolt-on’s Acquisition Strategy Close strategic gaps Technologies to complement Expand distribution channel (Product lines and geography) product portfo
Slide 19: Q4 Financial Results Update
Q4 Financial Results Update 19 Q4 local currency sales declined approximately 13% in Q4 2023, below prior guidance of a 7% to 8% decline due to unexpected shipping delays with a new external European logistics service provider. Delays impacted Global operations as our European logistics hub ship
Slide 20: Opportunities in a Dynamic Environment
Opportunities in a Dynamic Environment 20 De-globalization, new technologies and need for automation Pharma/Biopharma investments Semiconductor, battery technologies and Automation and productivity will continue to grow long term sustainable materials - Need for automation and - Re/Home-shorin
Slide 21: Summary
Summary 21 Significant Competitive Differentiators Global leader in fragmented markets Innovative product portfolio Largest direct sales network with excellent application knowledge Strong culture of execution and continuous improvement Well Developed & Ingrained Growth Strategies Sophisti
Slide 22: Thank You.
METTLER TOLEDO 22 Thank You.
Slide 23: Appendix: GAAP to Non-GAAP Measure Reconciliation
Appendix 23 GAAP to Non-GAAP Measure Reconciliation Dollars in Millions 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 GAAP consolidated net sales 2,342 2,379 2,486 2,395 2,508 2,725 2,936 3,009 3,085 3,718 3,920 Local currency (LC) sales growth 4% 1% 5% 3% 7% 8% 6% 5% 2% 18% 11% FX impact -
Slide 24: Preliminary financial information notice
24 The Company does not plan to release preliminary financial information on an ongoing basis. The financial information regarding the quarter ended December 31, 2023 included in this presentation is preliminary, is based on information available to management as of the date of this presentation, an
Slide 25: Adjusted Operating Profit
25 Adjusted Operating Profit The Company defines Adjusted Operating Profit as gross profit less research and development and selling, general and administrative expenses before amortization, interest, restructuring charges and other charges (income), net and taxes. The most directly comparable U.S.
Mettler-Toledo International — JP Morgan Healthcare Conference 2024 on 6ix